Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

US Anti-Drugs Work in Colombia Uses Cancer-Linked Herbicide

By Drug Discovery Trends Editor | March 23, 2015

In this Dec. 15, 2006, file photo, a plane sprays coca fields in San Miguel, on Colombia's southern border with Ecuador. The new labeling on Thursday, March 19, 2015, of the world’s most-popular weed killer as a likely cause of cancer could jeopardize the future of an aerial spraying program in Colombia that is the cornerstone of the U.S.-backed war on drugs. (AP Photo/William Fernando Martinez)New labeling on the world’s most popular weed killer as a likely cause of cancer is raising more questions for an aerial spraying program in Colombia that underpins U.S.-financed efforts to wipe out cocaine crops.

The International Agency for Research on Cancer, a French-based research arm of the World Health Organization, on Thursday reclassified the herbicide glyphosate as a carcinogen that poses a greater potential danger to industrial users than homeowners. The agency cited what it called convincing evidence that the herbicide produces cancer in lab animals and more limited findings that it causes non-Hodgkin’s lymphoma in humans.

The glyphosate-based herbicide Roundup is a mainstay of industrial agriculture worldwide, and it’s a preferred weapon for killing Colombian cocaine harvests. More than 4 million acres of land have been sprayed over the past two decades to kill coca plants, whose leaves produce cocaine.

The fumigation program, which is partly carried out by American contractors, long has provoked hostility from Colombia’s left, which likens it to the U.S. military’s use of the Agent Orange herbicide during the Vietnam War. Leftist rebels, currently in negotiations with the government to end a half-century conflict, are demanding an end to the spraying as part of any deal.

Daniel Mejia, a Bogota-based economist who is chairman of an expert panel advising the Colombian government on its drug strategy, said the report is by far the most authoritative and could end up burying the fumigation program.

“Nobody can accuse the WHO of being ideologically biased,” Mejia said, noting that questions already had been raised about the effectiveness of the spraying strategy and its potential health risks.

Mejia’s own research published last year found higher rates of skin problems and miscarriages in districts targeted by herbicides. It was based on a study of medical records from 2003 to 2007.

Colombia’s ombudsman office said it would seek suspension of the spraying program if the WHO results prove convincing.

But U.S. and Colombian government officials argue that cocaine does more health damage than aerial spraying.

“Without a doubt this reopens the debate on fumigation and causes us to worry,” Colombia Health Minister Alejandro Gaviria told The Associated Press on Saturday, referring to the WHO findings.

But Gaviria argued that the need to suppress cocaine harvests “transcends” other considerations.

Monsanto and other manufacturers of glyphosate-based products strongly rejected the WHO ruling. They cited a 2012 ruling by the U.S. Environmental Protection Agency that the herbicide was safe.

Colombia already has scaled back use of aerial herbicides in favor of more labor-intensive manual eradication efforts, partly in response to criticism by farmers.

Colombian officials say aerial spraying last year covered 55,000 hectares (136,000 acres), down from a 2006 peak of 172,000 hectares (425,000 acres).

Critics of the program concede that the government has improved safety standards, such as by avoiding herbicide flights during strong winds, and installing GPS devices on fumigation aircraft that keep records of plane movements and help investigators to determine the validity of farmers’ compensation claims.

In 2013, Colombia agreed to pay Ecuador $15 million to settle a lawsuit over economic and human damage linked to spraying along their common border.

Gen. Ricardo Restrepo, commander of the anti-narcotics police, said he had not seen the WHO warning, and Colombia’s herbicide spraying was proceeding as usual.

“My job is to carry out the strategy,” he said.

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE